Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
manages Allergy and Immunization clinic patient flow, ensuring efficient operations and patient care, and administers immunizations and Allergy Immunotherapy; Transcribes immunization records; Accurately
-
Institute can be found on our website https://www.ucl.ac.uk/cancer/ About the role We are seeking a self-motivated, enthusiatic post-doctoral research fellow to work in the Dendritic cell Immunotherapy lab
-
Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19
-
benefits package, including health and life insurance, generous paid leave and retirement programs. To learn more about USC benefits, access the "Working at USC" section on the Applicant Portal at https
-
. Characterization of the cellular and immunological mechanisms induced by a ribonucleoprotein-based vaccine targeting telomerase (TERT) in the context of anticancer immunotherapy Where to apply Website https
-
novel immunotherapies for cancer. Current areas of major focus include in depth studies of the molecular and cellular processes that govern T cell exhaustion, identification of new immune targets
-
: "Cytokine-induced universal memory NK cells for cancer immunotherapy: strategies to prevent rejection and enhance infiltration and antitumor activity." This project is funded by the Spanish State Research
-
Immunopathology Group, led by Dr. Francisco Borrego, to work on the project PID2024-162509OB-I00, entitled: "Cytokine-induced universal memory NK cells for cancer immunotherapy: strategies to prevent rejection and
-
the body’s immune system to fight cancer at all levels (https://cancer.osu.edu/piio ). Launched in July 2019 as part of a $102 Million pledge from Pelotonia (pelotonia.org), the PIIO represents Ohio State's
-
major challenges in brain delivery, immunotherapy, and the treatment of retinal, vascular, infectious, or other diseases. The candidate will lead projects aimed at engineering non-viral vectors capable